Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34+CD38- progenitor cells from patients with acute myeloid leukemia

Blood

Volumn 97, Issue 12, 2001, Pages 3882-3889

  Feuring Buske, Michaela ^a   Hogge, Donna E ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; HOE 33342;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANIMAL CELL; ARTICLE; BLOOD ANALYSIS; BONE MARROW; CELL CULTURE; CLINICAL ARTICLE; CYTOGENETICS; FEMALE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MALE; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; STEM CELL;

EID: 0035877989     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.12.3882     Document Type: Article

References (46)

1. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3:730-736.
2. Sutherland HJ, Blair A, Zapf RW. Characterization of a hierarchy in human acute myeloid leukemia progenitor cells. Blood. 1996;87:4754-4761.
3. Ailles LE, Gerhard B, Kawagoe H, Hogge DE. Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/severe combined immunodeficient mice. Blood. 1999;94:1761-1772.
4. Kawagoe H, Humphries RK, Blair A, Sutherland HJ, Hogge DE. Expression of Hox genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells. Leukemia. 1999;13:687-698.
5. + subpopulations of human bone marrow cells. Proc Natl Acad Sci U S A. 1994;91:12223-12227.
6. Bhatia M, Wang JCY, Kapp U, Bonnet D, Dick JE. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci U S A. 1997;94:5320-5325.
7. Conneally E, Cashman J, Petzer A, Eaves C. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc Natl Acad Sci U S A. 1997;94:9836-9841.
8. Hogge DE, Lansdorp PM, Reid D, Gerhard B, Eaves CJ. Enhanced detection, maintenance and differentiation of primitive human hematopoietic cells in cultures containing murine fibroblasts engineered to produce human Steel factor, interleukin-3 and granulocyte colony-stimulating factor. Blood. 1996;88:3765-3773.
9. Lemieux ME, Eaves CJ. Identification of properties that can distinguish primitive populations of stromal cell-responsive lympho-myeloid cells from cells that are stromal cell-responsive but lymphoid-restricted and cells that have lymphomyeloid potential but are also capable of competitively repopulating myeloablated recipients. Blood. 1996;88:1639-1648.
10. Blair A, Hogge DE, Ailles LE, Lansdorp PM, Sutherland HJ. Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo. Blood. 1997;89:3104-3112.
11. -. Blood. 1998;92:4325-4335.
12. Blair A, Sutherland HJ. Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit. Exp Hematol. 2000;28:660-671.
13. + subpopulations. Blood. 1995;86:2906-2912.
14. -) in acute myeloid leukemia. Blood. 1995;86:1139-1147.
15. Feuring-Buske M, Haase D, Konemann S, et al. Trisomy 4 in "stem cell-like" leukemic cells of a patient with AML. Leukemia. 1995;9:1318-1320.
16. - subpopulation of acute myeloid leukemia. Blood. 1996;87:2187-2194.
17. + cells. Exp Hematol. 1998;26:353-360.
18. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med. 1996;183:1797-1806.
19. Sato T, Laver JH, Ogawa M. Reversible expression of CD34 by murine hematopoietic stem cells. Blood. 1999;94:2548-2554.
20. Bhatia M, Bonnet D, Murdoch B, Gan OI, Dick J. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med. 1998;4:1038-1045.
21. Goodell MA, Rosenzweig M, Kim H, et al. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med. 1997;3:1337-1345.
22. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann Intern Med. 1985;103:620-625.
23. Allies LE, Gerhard B, Hogge DE. Detection and characterization of primitive malignant and normal progenitors in patients with acute myelogenous leukemia using long-term coculture with supportive feeder layers and cytokines. Blood. 1997;90:2555-2564.
24. Shultz LD, Schweitzer PA, Christianson SW, et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol. 1995;154:180-191.
25. Holyoake TL, Nicolini FE, Eaves CJ. Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. Exp Hematol. 1999;27:1418-1427.
26. Sievers EL, Appelbaum FR, Spielberger RT, et al. Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugate. Blood. 1999;93:3678-3684.
27. Hogge DE, Willman CL, Kreitman RJ, et al. Malignant progenitors from patients with acute myelogenous leukemia are sensitive to a diphtheria toxin-granulocyte macrophage-colony-stimulating factor fusion protein. Blood. 1998;92:589-595.
28. Fraser CC, Kaneshima H, Hansteen G, Kilpatrick M, Hoffman R, Chen BP. Human allogeneic stem cell maintenance and differentiation in long-term multilineage SCID-hu graft. Blood. 1995;86:1680-1693.
29. Nakauchi H. Hematopoietic stem cells: are they CD34-positive or CD34-negative? [news; comment]. Nat Med. 1998;4:1009-1010.
30. - hematopoietic stem cells using cell surface markers AC133 and CD7. Blood. 2000;95:2813-2820.
31. List AF. Role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia. Leukemia. 1996;10:937-942.
32. Pirker R, Wallner J, Geissler K, et al. MDR1 gene expression and treatment outcome in acute myeloid leukemia. J Natl Cancer Inst. 1991;83:708-712.
33. Schneider E, Cowan KH, Bader H, et al. Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia. Blood. 1995;85:186-193.
34. Lehne G, De Angelis P, Ciausen OP, Egeland T, Tsuruo T, Rugstad HE. Binding diversity of antibodies against external and internal epitopes of the multidrug resistance gene product P-glycoprotein. Cytometry. 1995;20:228-237.
35. -/effluxcases. Blood. 1995;86:2329-2342.
36. Huet S, Marie JP, Gualde N, Robert J. Reference method for detection of Pgp-mediated multidrug resistance in human hematological malignancies: a method validated by the laboratories of the French Drug Resistance Network. Cytometry. 1998;34:248-256.
37. Ling V. Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother Pharmacol. 1997;40:S3-S8.
38. +-ATPase-dependent activity of multidrug resistance-associated protein in homoharringtonine-resistant human leukemic K562 cells. Leukemia. 1998;12:1539-1544.
39. Ross DD. Novel mechanisms of drug resistance in leukemia. Leukemia. 2000;14:467-473.
40. San Miguel JF, Martinez A, Macedo A, et al. Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients. Blood. 1997;90:2465-2470.
41. Campana D, Coustan-Smith E, Janossy G. The immunologic detection of minimal residual disease in acute leukemia. Blood. 1990;76:163-171.
42. Drach J, Drach D, Glassl H, Gattringer C, Huber H. Flow cytometric determination of atypical antigen expression in acute leukemia for the study of minimal residual disease. Cytometry. 1992;13:893-901.
43. Wormann B. Implications of detection of minimal residual disease. Curr Opin Oncol. 1993;5:3-12.
44. - lymphoid progenitor in human umbilical cord blood. Blood. 2000;96:2125-2133.
45. - subset of human fetal liver SP cells [abstract]. Blood. 2000;96,278.
46. Ailles LE, Humphries RK, Thomas TE, Hogge DE. Retroviral marking of acute myelogenous leukemia progenitors that initiate long-term culture and growth in immunodeficient mice. Exp Hematol. 1999;27:1609-1620.